Nonprofits›Methodist Hospital
Health Care
Methodist Hospital
HOUSTON, TX
Total revenue
—
Total expenses
—
Net assets
—
Grants received
$21.6M
104 grants
EIN
870721923
Tax year
—
Grants received
Showing 104 of 104
FromAmountPurposeYear
$15K
STUDIES FLUID FLOW THOUGH VERY SMALL CHANNELS (NANOFLUIDICS) TO DEVELOP A REMOTELY CONTROLLED DRUG DELIVERY IMPLANT TO RELEASE SPECIFIC AMOUNTS OF A DRUG AND PROVIDE INDIVIDUALIZED TREATMENT.
2023
$87K
LEVERAGES THE EXTREME ENVIRONMENT OF SPACE TO TEST THE PERFORMANCE OF FIVE PROPRIETARY CARBON FIBER MATERIALS, INCLUDING FORGED AND 3D-PRONTED CARBON FIBER COMPOSITES, DEVELOPED BY AUTOMOBILI LAMBORGHINI FOR AEROSPACE APPLICATIONS.
2022
$75K
RESEARCH TO ADVANCE THE SCIENCE AND PRACTICE OF ORGAN TRANSPLANTATION
2022
$39K
LEVERAGES THE EXTREME ENVIRONMENT OF SPACE TO TEST THE PERFORMANCE OF FIVE PROPRIETARY CARBON FIBER MATERIALS, INCLUDING FORGED AND 3D-PRONTED CARBON FIBER COMPOSITES, DEVELOPED BY AUTOMOBILI LAMBORGHINI FOR AEROSPACE APPLICATIONS.
2021
$336K
LEVERAGES THE EXTREME ENVIRONMENT OF SPACE TO TEST THE PERFORMANCE OF FIVE PROPRIETARY CARBON FIBER MATERIALS, INCLUDING FORGED AND 3D-PRONTED CARBON FIBER COMPOSITES, DEVELOPED BY AUTOMOBILI LAMBORGHINI FOR AEROSPACE APPLICATIONS.
2019
$184K
ALZHEIMER'S DISEASE RESEARCH BY ALIREZA FARIDAR, MD, ENTITLED: (A2019083F)
2018
$20K
LEVERAGES THE EXTREME ENVIRONMENT OF SPACE TO TEST THE PERFORMANCE OF FIVE PROPRIETARY CARBON FIBER MATERIALS, INCLUDING FORGED AND 3D-PRONTED CARBON FIBER COMPOSITES, DEVELOPED BY AUTOMOBILI LAMBORGHINI FOR AEROSPACE APPLICATIONS.
2018
$51K
NANOFLUIDICS STUDY TO DEVELOP A REMOTELY CONTROLLED, TUNABLE DRUG DELIVERY IMPLANT
2017
Funded by
$21.6M from 42 funders · 104 grants · 2017–2024
American Heart Association Inc
$7.1M · 6 grants · 2018–2023
Alzheimer's Disease & Related Disorders
$2.6M · 2 grants · 2020–2023
University Of Pittsburgh
$1.2M · 7 grants · 2017–2023
Mayo Clinic
$1.0M · 4 grants · 2020–2024
The Leukemia & Lymphoma Societyinc
$1M · 2 grants · 2022–2023
Breakthrough T1D
$940K · 3 grants · 2020–2022
University Of Southern California
$930K · 1 grant · 2023
Amyotrophic Lateral Sclerosis Assn
$631K · 3 grants · 2018–2020
Details
EIN870721923
NTEE codeE20
Subsection03
Ruling date2010-09